2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N15705
    Demethylflavasperone-10-O-β-d-glucopyranosyl-6-O-β-d-apiofuranoside
    Demethylflavasperone-10-O-β-d-glucopyranosyl-6-O-β-d-apiofuranoside (compound 2) is a naphthopyrone glycoside found in Senna tora sprouts.
    Demethylflavasperone-10-O-β-d-glucopyranosyl-6-O-β-d-apiofuranoside
  • HY-P991131
    Daretabart
    		Inhibitor
    Daretabart is a humanized IgG1K antibody targeting GD2, which can be used for anti-tumor research. The corresponding isotype control is: Human lgG1 kappa, lsotype Control (HY-P99001).
    Daretabart
  • HY-151121
    Anticancer agent 80
    Anticancer agent 80 (Compound 3c) is an anticancer agent. Anticancer agent 80 exhibits the dark cytotoxicity against T47-D with IC50 of 10.14 µM.
    Anticancer agent 80
  • HY-175174
    Antiproliferative agent-73
    Antiproliferative agent-73 (Compound 7) is an antiproliferative agent. Antiproliferative agent-73 significantly inhibits proliferation of human cancer cells with excellent cytotoxicity. Antiproliferative agent-73 has potent anticancer activity with IC50s of 15.20, 18.18, 20.20 and 13.23  μM for HepG2, MCF-7, HCT-116 and WI38 cells, respectively. Antiproliferative agent-73 can be used for cancers research, such as breast, colorectal and liver cancer.
    Antiproliferative agent-73
  • HY-P99206A
    Naxitamab (Mouse IgG1)
    Naxitamab (Hu3F8) (Mouse IgG1) is a mouse-derived IgG1 monoclonal antibody targeting the diazoglycoside GD2 (hu3F8). Naxitamab can be used in the research of neuroblastoma, osteosarcoma, and other GD2-positive cancers.
    Naxitamab (Mouse IgG1)
  • HY-N6600R
    Octadecane (Standard)
    Octadecane is an alkane that is used to store thermal energy at ambient temperature as a phase change material.
    Octadecane (Standard)
  • HY-P991184
    Anti-LY6G6D Antibody (1G4)
    Anti-LY6G6D Antibody (1G4) is a humanized IgG1 monoclonal antibody that targets LY6G6D. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-LY6G6D Antibody (1G4)
  • HY-116220
    Mcl1-IN-14
    Mcl1-IN-14 (compound 5) is a reversible covalent inhibitor of Mcl-1 with the activity of inhibiting Mcl-1. Mcl1-IN-14 covalently targets the non-catalytic lysine side chain of Mcl-1 and has higher potency than non-covalent counterparts, which can be used to develop Mcl-1 inhibitory compounds and study related biological phenomena.
    Mcl1-IN-14
  • HY-N9304
    Fern-7-en-19α-ol
    Fern-7-en-19α-ol (9a-Hydroxyferna-7,9(11)-diene) is a triterpenoid compound isolated from Adiantum caudatum.
    Fern-7-en-19α-ol
  • HY-N15627
    Xanthevodine
    Xanthevodine (NSC 94652) is an alkaloid that can be extracted from the leaves of Acronychia baueri Schott.
    Xanthevodine
  • HY-109036A
    (S)-Landipirdine
    (S)-Landipirdine ((S)-RO5025181), a selective and potent 5-HT6R antagonist, significantly impacts the hERG pharmacophore and serves as a valuable tool for investigating neurological disorders, particularly within the context of Alzheimer's disease.
    (S)-Landipirdine
  • HY-N16055
    Cochliomycin B
    Cochliomycin B is a natural product that can be isolated from Gorgonian-Derived Fungus Cochliobolus lunatus.
    Cochliomycin B
  • HY-176543
    Dityramine
    Dityramine (Bityramine) is an hypertensive agent.
    Dityramine
  • HY-149077
    2′-Deoxy-5-methoxyuridine
    2′-Deoxy-5-methoxyuridine is a uridine analogue. Uridine has potential antiepileptic effects, and its analogs can be used to study anticonvulsant and anxiolytic activities, as well as to develop new antihypertensive agents.
    2′-Deoxy-5-methoxyuridine
  • HY-164320
    Anticancer agent 245
    Anticancer agent 245 (Compound 115) inhibits proliferation of cancer cell SKOV3, MDA-MB-231 and HCT-116 with IC50 of 0.021, 0.056 and 0.11 μM, respectively. Anticancer agent 245 exhibits antitumor efficacy in mice and good pharmacokinetic characteristics in rat models.
    Anticancer agent 245
  • HY-159820
    Veonetinib
    Veonetinib (example 3) is a potent inhibitor of tyrosine kinase, with the IC50 of 0.1 μM and 0.4 μM in A549 cells and LOVO cells, respectively.
    Veonetinib
  • HY-153184
    GalNAc-L96 free base
    GalNAc-L96 free base is a triantennary GalNAc ligand that can be used for the synthesis of GalNAc-siRNA. GalNAc is a ligand of ASGPR (asialoglycoprotein receptor).
    GalNAc-L96 free base
  • HY-147053
    2-(Diethylamino)ethyl (3-(octyloxy)phenyl)carbamate hydrochloride
    2-(Diethylamino)ethyl (3-(octyloxy)phenyl)carbamate hydrochloride is a small molecule compound.
    2-(Diethylamino)ethyl (3-(octyloxy)phenyl)carbamate hydrochloride
  • HY-116284A
    Methyl β-D-glucopyranoside hemihydrate
    Methyl β-D-glucopyranoside (Methyl β-D-glucoside) hemihydrate is a hemihydrate compound. Methyl β-D-glucopyranoside hemihydrate less reactive at higher PH. The formation of Methyl β-D-glucopyranoside hemihydrate is stereospecific.
    Methyl β-D-glucopyranoside hemihydrate
  • HY-155726
    Cy-FBP/SBPase-IN-1
    Cy-FBP/SBPase-IN-1 (compound S5) is a Cy-FBP/SBPase inhibitor, which is an important regulatory enzyme in cyanobacterial photosynthesis. Thus Cy-FBP/SBPase-IN-1 inhibits Calvin cycle and photosystem, and decreases photosynthetic efficiency in cyanobacterial photosynthesis. Cy-FBP/SBPase-IN-1 potently inhibits the growth of cyanobacteria, as well as Synechocystis sp.PCC6803. Cy-FBP/SBPase-IN-1 shows safety profile in human-derived cells and zebrafish models.
    Cy-FBP/SBPase-IN-1
Cat. No. Product Name / Synonyms Application Reactivity